HER2-positive breast cancer treated with pertuzumab, trastuzumab, and chemotherapy, lived about 16 months longer.
Trastuzumab in combination with standard chemotherapy for breast cancer leads to better outcomes.
Cediranib with carboplatin and paclitaxel improved tumor shrinkage in patients with recurrent cervical cancer.
A biomarker in the blood that may indicate early development of pancreatic cancer
Findings based on large retrospective study of patients with type 2 diabetes.
Researchers have successfully rendered Bacillus anthracis bacteria nontoxic to deliver antibody mimics to cancer cells.
A particular protein in the bone marrow prompts stem cells to repair the human blood system after chemotherapy and radiation
Increased levels of gelsolin associated with aggressive forms of ovarian cancer.
A gene called Leo1 leads to an increased risk for developing acute myelogenous leukemia (AML).
NSAIDs should be prescribed with caution, especially in patients already at a higher risk of VTE.
Researchers found that FDG-PET technology was associated with more false positive results.
Alectinib may be effective treatment for patients with non-small cell lung cancer (NSCLC), refractory to crizotinib.
Ibrutinib in combination with ABT-199 may be effective for mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL).
CX-5461, which that inhibits RNA polymerase 1, may improve survival for patients with highly aggressive acute myeloid leukemia.
Description of new approach to combat drug resistance in hematologic malignancies.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|